In the past week, APLS stock has gone down by -7.24%, with a monthly decline of -10.00% and a quarterly plunge of -41.32%. The volatility
The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has decreased by -1.77 when compared to last closing price of 20.34.Despite this, the company has seen
The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has increased by 2.39 when compared to last closing price of 17.96. Despite this, the company has
Moreover, the 36-month beta value for APLS is 0.79. Analysts have varying opinions on the stock, with 11 analysts rating it as a “buy,” 3
The stock price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has plunged by -1.86 when compared to previous closing price of 19.33, but the company has
In the past week, APLS stock has gone down by -17.55%, with a monthly decline of -25.62% and a quarterly plunge of -45.61%. The volatility
The stock price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has jumped by 7.20 compared to previous close of 21.87. Despite this, the company has seen
The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has increased by 0.13 when compared to last closing price of 23.76. Despite this, the company has
The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has increased by 1.64 when compared to last closing price of 24.41. Despite this, the company has
© 2024, Powered by Smart TechOne
